A detailed history of Shelton Capital Management transactions in Amgen Inc stock. As of the latest transaction made, Shelton Capital Management holds 174,744 shares of AMGN stock, worth $50.3 Million. This represents 1.46% of its overall portfolio holdings.

Number of Shares
174,744
Previous 77,391 125.79%
Holding current value
$50.3 Million
Previous $24.2 Million 132.85%
% of portfolio
1.46%
Previous 0.67%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$309.38 - $337.38 $30.1 Million - $32.8 Million
97,353 Added 125.79%
174,744 $56.3 Million
Q2 2024

Aug 13, 2024

SELL
$262.75 - $319.31 $66,475 - $80,785
-253 Reduced 0.33%
77,391 $24.2 Million
Q1 2024

May 15, 2024

SELL
$268.87 - $324.56 $1.36 Million - $1.64 Million
-5,045 Reduced 6.1%
77,644 $22.1 Million
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $856,339 - $966,052
-3,349 Reduced 3.89%
82,689 $23.8 Million
Q3 2023

Nov 14, 2023

BUY
$218.65 - $271.46 $4.05 Million - $5.02 Million
18,510 Added 27.41%
86,038 $23.1 Million
Q2 2023

Aug 10, 2023

BUY
$214.27 - $253.37 $2.43 Million - $2.87 Million
11,346 Added 20.2%
67,528 $15 Million
Q1 2023

May 11, 2023

BUY
$225.79 - $275.2 $3.18 Million - $3.88 Million
14,093 Added 33.48%
56,182 $13.6 Million
Q4 2022

Feb 13, 2023

SELL
$229.03 - $291.01 $3.16 Million - $4.02 Million
-13,801 Reduced 24.69%
42,089 $11.1 Million
Q3 2022

Nov 14, 2022

SELL
$224.46 - $253.15 $381,357 - $430,101
-1,699 Reduced 2.95%
55,890 $12.6 Million
Q2 2022

Aug 11, 2022

SELL
$230.71 - $256.74 $69,213 - $77,022
-300 Reduced 0.52%
57,589 $14 Million
Q1 2022

May 12, 2022

BUY
$219.27 - $242.57 $10,305 - $11,400
47 Added 0.08%
57,889 $14 Million
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $218,569 - $250,132
1,099 Added 1.94%
57,842 $13 Million
Q3 2021

Nov 15, 2021

SELL
$212.27 - $248.7 $22,500 - $26,362
-106 Reduced 0.19%
56,743 $12.1 Million
Q2 2021

Aug 12, 2021

SELL
$233.58 - $259.14 $2.1 Million - $2.33 Million
-9,000 Reduced 13.67%
56,849 $13.9 Million
Q1 2021

May 14, 2021

BUY
$221.91 - $258.6 $779,569 - $908,461
3,513 Added 5.64%
65,849 $16.4 Million
Q4 2020

Feb 16, 2021

SELL
$216.38 - $257.67 $47,603 - $56,687
-220 Reduced 0.35%
62,336 $14.3 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $23,699 - $26,355
-101 Reduced 0.16%
62,556 $15.9 Million
Q2 2020

Aug 12, 2020

BUY
$197.81 - $242.74 $1.61 Million - $1.98 Million
8,162 Added 14.98%
62,657 $14.8 Million
Q1 2020

May 13, 2020

SELL
$182.24 - $241.7 $248,393 - $329,437
-1,363 Reduced 2.44%
54,495 $11 Million
Q4 2019

Feb 11, 2020

SELL
$189.21 - $243.2 $370,851 - $476,672
-1,960 Reduced 3.39%
55,858 $13.5 Million
Q3 2019

Nov 13, 2019

SELL
$174.11 - $208.62 $1.8 Million - $2.16 Million
-10,354 Reduced 15.19%
57,818 $11.2 Million
Q2 2019

Aug 14, 2019

BUY
$166.7 - $195.41 $9.17 Million - $10.8 Million
55,033 Added 418.85%
68,172 $12.6 Million
Q1 2019

May 10, 2019

SELL
$180.87 - $203.88 $10.2 Million - $11.5 Million
-56,387 Reduced 81.1%
13,139 $69.2 Million
Q4 2018

Jan 31, 2019

SELL
$178.4 - $208.25 $1.1 Million - $1.28 Million
-6,164 Reduced 8.14%
69,526 $13.5 Million
Q3 2018

Nov 14, 2018

SELL
$185.29 - $208.89 $448,216 - $505,304
-2,419 Reduced 3.1%
75,690 $15.7 Million
Q2 2018

Aug 10, 2018

SELL
$166.05 - $186.51 $3.17 Million - $3.57 Million
-19,117 Reduced 19.66%
78,109 $14.4 Million
Q1 2018

May 15, 2018

BUY
$169.43 - $198.0 $415,103 - $485,100
2,450 Added 2.59%
97,226 $16.6 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $3.79 Million - $4.24 Million
22,483 Added 31.1%
94,776 $16.5 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $469,917 - $536,519
2,809 Added 4.04%
72,293 $13.5 Million
Q2 2017

Aug 14, 2017

BUY
N/A
5,913 Added 9.3%
69,484 $12 Million
Q1 2017

Nov 28, 2017

BUY
N/A
3,928 Added 6.59%
63,571 $10.4 Million
Q4 2016

Nov 29, 2017

SELL
N/A
-200 Reduced 0.33%
59,643 $8.72 Million
Q3 2016

Dec 06, 2017

BUY
N/A
200 Added 0.34%
59,843 $9.98 Million
Q3 2016

Dec 04, 2017

BUY
N/A
59,643
59,643 $8.72 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $154B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Shelton Capital Management Portfolio

Follow Shelton Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Shelton Capital Management with notifications on news.